An integrated immunoinformatic approach to design a novel multiepitope chimeric vaccine against <i>Mycoplasma phocimorsus</i> as a causal agent of bloodstream infections.

Front Immunol · 2025 · PMC12714920 · PMID 41425596

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Overall, the highly significant percentage of the global population justifies vaccine design. 3.6.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

An integrated immunoinformatic approach to design a novel multiepitope chimeric vaccine against &lt;i&gt;Mycoplasma phocimorsus&lt;/i&gt; as a causal agent of bloodstream infections.

The sentences

An integrated immunoinformatic approach to design a novel multiepitope chimeric vaccine against <i>Mycoplasma phocimorsus</i> as a causal agent of bloodstream infections.